8-K//Current report
Fulcrum Therapeutics, Inc. 8-K
Accession 0001193125-22-168375
$FULCCIK 0001680581operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:30 PM ET
Size
147.0 KB
Accession
0001193125-22-168375
Documents
- 8-Kd318754d8k.htmPrimary
8-K
- EX-101.SCHfulc-20220603.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABfulc-20220603_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREfulc-20220603_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLd318754d8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-22-168375-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001680581
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:30 PM ET
- Size
- 147.0 KB